Infectious disease tests

Identify the target before the clinical context

A respiratory context does not by itself define what a test detects. SARS-CoV-2, influenza A or B and group A streptococcus are different targets. A combined device has an explicitly specified marker list rather than automatically detecting every infectious agent. Strep throat likewise does not name an exhaustive panel for every cause of sore throat. This distinction gives each subfamily concrete meaning and prevents broad condition names from replacing the actual analytical scope of the device.

Antigens, genetic material and other markers

Antigen methods look for components of an agent, while molecular methods concern genetic material. These principles use different material systems. An antibody test represents another target and should not be equated with direct agent detection. External format therefore does not summarise technology. The marker list, reactive support and any reading instrument need consideration together without a general performance promise. Multiple outputs and compact housing are presentation characteristics rather than proof that two tests use an identical analytical method.

Samples, reagents and controls

Nasal swabs, nasopharyngeal sampling and throat samples are not interchangeable terms. The system defines the accepted sample and associated components. Tubes, extraction solutions and reading supports may be separate or integrated according to the construction. Included controls have a different role from samples collected from people. Similar-looking accessories do not prove compatibility; intended combinations remain those defined for the device. The sample type, swab, extraction components and analytical target together define the material scope of the intended infectious disease test.

Intended users and reading methods

Self-tests and professional tests have their own purposes. Unit count, appearance and the word rapid do not determine that status. Reading may be visual or instrument-based, and control information differs from result areas. Performance and interpretation conditions belong to the documentation and applicable professional context. The infectious target, accepted sample and kit components therefore provide complementary ways to describe each testing family and its intended analytical scope. The distinction preserves useful technical information while leaving clinical assessment separate from the construction of the supplied kit.

Frequently asked questions